| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.31B | 1.04B | 909.77M | 691.06M | 695.67M | 731.62M |
| Gross Profit | 775.38M | 653.18M | 616.19M | 606.68M | 653.15M | 573.44M |
| EBITDA | 201.32M | 277.25M | 212.42M | 254.05M | 270.18M | 138.12M |
| Net Income | 147.07M | 195.46M | 144.68M | 166.07M | 175.89M | 83.65M |
Balance Sheet | ||||||
| Total Assets | 26.73B | 18.03B | 17.36B | 16.99B | 16.81B | 14.93B |
| Cash, Cash Equivalents and Short-Term Investments | 1.09B | 1.92B | 1.72B | 2.11B | 4.26B | 1.98B |
| Total Debt | 1.16B | 538.63M | 736.98M | 1.14B | 485.16M | 496.31M |
| Total Liabilities | 22.90B | 15.36B | 15.06B | 14.85B | 14.60B | 12.80B |
| Stockholders Equity | 3.83B | 2.68B | 2.30B | 2.14B | 2.21B | 2.13B |
Cash Flow | ||||||
| Free Cash Flow | 253.19M | 115.78M | 126.92M | 559.21M | 122.14M | 53.97M |
| Operating Cash Flow | 256.43M | 129.43M | 148.55M | 574.04M | 142.66M | 82.24M |
| Investing Cash Flow | -1.03B | -298.04M | -55.40M | -2.04B | -660.00M | -1.27B |
| Financing Cash Flow | 586.31M | 459.30M | 132.21M | 167.64M | 1.76B | 1.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $3.78B | 18.63 | 5.51% | 3.05% | 11.05% | -10.78% | |
79 Outperform | $4.47B | 16.05 | 8.60% | ― | 5.19% | 3454.95% | |
77 Outperform | $4.12B | 12.94 | 9.23% | 3.02% | 5.63% | 65.11% | |
74 Outperform | $4.62B | 78.26 | 1.32% | 2.72% | -1.18% | -89.13% | |
72 Outperform | $3.48B | 18.43 | 4.54% | 2.47% | 20.26% | -35.00% | |
71 Outperform | $3.60B | 10.47 | 10.92% | 3.52% | 9.60% | 20.38% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On November 10, 2025, Dr. Richard Heyer informed Renasant Corporation that he will not seek re-election as a director at the company’s 2026 Annual Meeting of Shareholders, scheduled for April 28, 2026. Dr. Heyer will also retire from the board of Renasant Bank, a subsidiary of the company. His decision was not due to any disagreements with the company’s operations, policies, or practices.
The most recent analyst rating on (RNST) stock is a Hold with a $38.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.
In the third quarter of 2025, Renasant Corporation reported a net income of $59.8 million and a diluted EPS of $0.63. The company experienced a 9.9% annualized increase in loans while deposits decreased due to public fund seasonality. The merger with The First Bancshares, Inc. presents opportunities and risks, including integration challenges and regulatory scrutiny, which could impact Renasant’s financial performance and growth strategy.
The most recent analyst rating on (RNST) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.
Renasant Corporation announced its third-quarter 2025 earnings, reporting a net income of $59.8 million. The company experienced strong loan growth and profit improvement, with a net interest income of $228.1 million and a net interest margin of 3.85%. The integration with The First Bancshares, Inc. is progressing well, positioning Renasant to meet its financial goals. However, the company faced challenges such as a decrease in deposits and an increase in nonperforming loans. The Board approved a $150 million stock repurchase program, replacing the previous $100 million program.
The most recent analyst rating on (RNST) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Renasant stock, see the RNST Stock Forecast page.